MDWD
MediWound Ltd.
MDWD lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
MDWD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Strong |
MDWD's balance sheet is currently strong, but its revenue, profitability and cash flow are weak.
MDWD PE Valuation
MDWD has no meaningful PE right now: it lost money over the past year.
MDWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect MDWD's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MDWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.60 | +$1.04 |
| Q1 2026 | -$2.26 | -$0.17 |
| Q4 2025 | -$2.10 | +$0.97 |
| Q3 2025 | -$1.90 | +$1.00 |
| Q2 2025 | -$2.64 | -$0.48 |
| Q1 2025 | -$2.09 | -$0.71 |
| Q4 2024 | -$3.07 | -$2.30 |
| Q3 2024 | -$2.90 | -$1.14 |
MDWD is still losing money, but far less than before: $1.60 per share over the past year, against $3.85 at its worst in late 2022.
MDWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.1M | -46% |
| Q1 2026 | $1.5M | -63% |
| Q4 2025 | $1.9M | -68% |
| Q3 2025 | $5.4M | +25% |
| Q2 2025 | $5.7M | +13% |
| Q1 2025 | $4M | -20% |
| Q4 2024 | $5.8M | +9.4% |
| Q3 2024 | $4.4M | -8.8% |
MDWD's revenue has slid since its 2022 peak: $3M last quarter, down 46% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -306% | -206 points |
| Q1 2026 | -541% | -409 points |
| Q4 2025 | -418% | -314 points |
| Q3 2025 | -120% | -3.5 points |
| Q2 2025 | -100% | -12 points |
| Q1 2025 | -132% | -57 points |
| Q4 2024 | -104% | -31 points |
| Q3 2024 | -117% | -53 points |
MDWD's operating margin was −306% last quarter, down 206 points from the same quarter a year ago, near the bottom of its range since 2019.
MDWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$10.1M | -$3.3M |
| Q1 2026 | -$8.6M | -$3.5M |
| Q4 2025 | -$5.5M | -$3M |
| Q3 2025 | -$4.3M | +$664K |
| Q2 2025 | -$6.8M | -$166K |
| Q1 2025 | -$5.1M | +$193K |
| Q4 2024 | -$2.4M | +$2.4M |
| Q3 2024 | -$4.9M | -$12K |
MDWD has burned cash in almost every quarter: −$28M over the past year, against −$19M the year before.
MDWD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -11.2x | Net Cash |
| Q4 2023 | -2.1x | Net Cash |
| Q1 2020 | -1.1x | Net Cash |
| Q4 2019 | -1.3x | Net Cash |
| Q3 2019 | -0.5x | Net Cash |
MDWD has more cash than debt.
MDWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 59.4 | Neutral |
MDWD's weekly RSI is 44 (neutral) and its Stochastic is 59 (neutral).
MDWD PE vs Healthcare Sector
| Metric | MDWD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MDWD has no meaningful PE right now: it lost money over the past year.
MDWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 0.5% below |
| 20 week MA | $13.5 | 4.1% below |
| 50 week MA | $15.5 | 17% below |
| 100 week MA | $16.9 | 23% below |
| 200 week MA | $15.1 | 14% below |
MDWD is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MDWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.1 | $28.6 | +35% |
| 2021 | $28.6 | $15.8 | -45% |
| 2022 | $15.8 | $11.5 | -27% |
| 2023 | $11.5 | $10.2 | -12% |
| 2024 | $10.2 | $17.7 | +74% |
| 2025 | $17.7 | $18.8 | +6.2% |
| 2026 YTD | $18.8 | $13.0 | -31% |
MDWD has finished lower in three of the last six years. It's down 31% so far in 2026.